Consistently, breast cancer tissues that were CD44+CD24− had higher levels of HIF-2α (not HIF-1α), suggesting that patients with higher level of HIF-2α are likely to have a higher percentage of stem-like cells in their cancer tissues (Figs. 1F and S1F). The gene discussed is CD44; the disease is breast carcinoma.